What this instrument does
The federal government registered the Therapeutic Goods (Therapeutic Goods Advertising Code) Amendment (Standards for Labelling Consequential Amendments) Instrument 2026 on 29 September 2026. The instrument is currently in force.
The amendment makes consequential changes to the Therapeutic Goods (Therapeutic Goods Advertising Code) Instrument 2021. The purpose of these changes is to align the Advertising Code with updated Standards for Labelling of therapeutic goods.
What the source does not specify
The source document does not identify which exact labelling standards triggered the changes, what the substantive amendments are in detail, or which types of therapeutic goods or advertisers are affected.
Administration
This instrument is administered by the Department of Health, Disability and Ageing.
Key actions
- Review the full instrument text at https://www.legislation.gov.au/F2026L01329 to read the specific amendments made to the Therapeutic Goods Advertising Code Instrument 2021.
- If your business advertises or labels therapeutic goods, check whether the updated labelling standards referenced in this instrument change any requirements that apply to your products.
- Contact the Department of Health, Disability and Ageing for clarification on how these consequential amendments apply to your situation.
This is a plain-English summary for information only, not legal or compliance advice. Always check the official source or consult a qualified professional.